Gfg Capital, LLC Abbott Laboratories Transaction History

Gfg Capital, LLC

$385 Million
Q2 2024

A detailed history of Gfg Capital, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Gfg Capital, LLC holds 4,019 shares of ABT stock, worth $456,719. This represents 0.11% of its overall portfolio holdings.

Number of Shares

4,019

Previous 4,028 0.22%

Holding current value

$456,719

Previous $457,000 8.75%

% of portfolio

0.11%

Previous 0.04%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 22, 2024	SELL	$100.73 - $112.44 $906 - $1,011	-9 Reduced 0.22%	4,019 $417,000
Q1 2024 May 15, 2024	BUY	$109.52 - $120.96 $130,000 - $143,579	1,187 Added 41.78%	4,028 $457,000
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $116,345 - $142,416	-1,290 Reduced 31.23%	2,841 $312,000
Q3 2023 Nov 14, 2023	SELL	$95.53 - $114.62 $37.8 Million - $45.4 Million	-395,956 Reduced 98.97%	4,131 $400,000
Q3 2023 Nov 13, 2023	BUY	$95.53 - $114.62 $37.8 Million - $45.4 Million	395,940 Added 9547.62%	400,087 $38.7 Million
Q2 2023 Jul 28, 2023	SELL	$100.78 - $112.29 $55,429 - $61,759	-550 Reduced 11.71%	4,147 $452,000
Q1 2023 May 05, 2023	BUY	$96.86 - $114.01 $92,404 - $108,765	954 Added 25.49%	4,697 $475,000
Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $215,120 - $252,369	-2,263 Reduced 37.68%	3,743 $411,000
Q3 2022 Nov 08, 2022	BUY	$96.76 - $112.03 $39,961 - $46,268	413 Added 7.38%	6,006 $581,000
Q2 2022 Jul 25, 2022	SELL	$102.07 - $123.37 $405,524 - $490,149	-3,973 Reduced 41.53%	5,593 $608,000
Q1 2022 Apr 27, 2022	SELL	$114.02 - $139.04 $455,851 - $555,881	-3,998 Reduced 29.48%	9,566 $1.13 Million
Q4 2021 Feb 07, 2022	BUY	$115.53 - $141.46 $38,702 - $47,389	335 Added 2.53%	13,564 $1.91 Million
Q3 2021 Oct 13, 2021	BUY	$116.66 - $129.06 $179,306 - $198,365	1,537 Added 13.15%	13,229 $1.56 Million
Q2 2021 Jul 12, 2021	BUY	$105.79 - $124.53 $5,606 - $6,600	53 Added 0.46%	11,692 $1.36 Million
Q1 2021 Apr 28, 2021	BUY	$108.84 - $128.23 $12,190 - $14,361	112 Added 0.97%	11,639 $1.4 Million
Q4 2020 Jan 28, 2021	BUY	$105.0 - $114.42 $14,700 - $16,018	140 Added 1.23%	11,527 $1.26 Million
Q3 2020 Oct 19, 2020	SELL	$91.64 - $111.29 $8,614 - $10,461	-94 Reduced 0.82%	11,387 $1.24 Million
Q2 2020 Jul 17, 2020	BUY	$76.57 - $98.0 $29,632 - $37,926	387 Added 3.49%	11,481 $1.05 Million
Q1 2020 Apr 23, 2020	BUY	$62.82 - $91.86 $353,111 - $516,345	5,621 Added 102.7%	11,094 $875,000
Q4 2019 Feb 10, 2020	BUY	$78.51 - $87.4 $429,685 - $478,340	5,473 New	5,473 $475,000

Others Institutions Holding ABT

# of Institutions

3,136

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $199B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gfg Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gfg Capital, LLC with notifications on news.

Account